| 标题 |
A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance 阿帕替尼联合长春瑞滨治疗难治性HER2阴性乳腺癌的II期临床研究及其耐药的代谢意义
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 |